Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8641) 8641
Book Chapter (230) 230
Publication (33) 33
Newsletter (23) 23
Dissertation (15) 15
Book / eBook (13) 13
Conference Proceeding (13) 13
Magazine Article (12) 12
Newspaper Article (7) 7
Streaming Video (2) 2
Book Review (1) 1
Government Document (1) 1
Journal / eJournal (1) 1
Paper (1) 1
Patent (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6431) 6431
science & technology (6005) 6005
life sciences & biomedicine (5922) 5922
administration, oral (4755) 4755
female (3267) 3267
anticoagulants - administration & dosage (3108) 3108
male (3093) 3093
anticoagulants (2895) 2895
aged (2520) 2520
cardiovascular system & cardiology (2498) 2498
atrial fibrillation (2307) 2307
anticoagulants - therapeutic use (2256) 2256
middle aged (2234) 2234
anticoagulants - adverse effects (1977) 1977
risk factors (1750) 1750
cardiac & cardiovascular systems (1517) 1517
treatment outcome (1508) 1508
warfarin (1483) 1483
atrial fibrillation - drug therapy (1412) 1412
hematology (1400) 1400
adult (1394) 1394
stroke (1387) 1387
biological and medical sciences (1274) 1274
medical sciences (1260) 1260
aged, 80 and over (1224) 1224
peripheral vascular disease (1208) 1208
stroke - prevention & control (1114) 1114
hemorrhage - chemically induced (1092) 1092
thromboembolism (1079) 1079
oral anticoagulation (999) 999
atrial fibrillation - complications (980) 980
abridged index medicus (946) 946
general & internal medicine (870) 870
anticoagulation (824) 824
warfarin - administration & dosage (822) 822
rivaroxaban (815) 815
retrospective studies (790) 790
medicine, general & internal (780) 780
pharmacology & pharmacy (769) 769
medicine & public health (757) 757
time factors (754) 754
international normalized ratio (750) 750
thrombosis (737) 737
care and treatment (725) 725
dabigatran (724) 724
cardiac arrhythmia (708) 708
warfarin - therapeutic use (695) 695
bleeding (694) 694
patients (676) 676
risk assessment (661) 661
thromboembolism - prevention & control (659) 659
stroke - etiology (647) 647
surgery (643) 643
analysis (629) 629
drug therapy (609) 609
venous thromboembolism (609) 609
vitamin k - antagonists & inhibitors (602) 602
pharmacology. drug treatments (601) 601
warfarin - adverse effects (587) 587
direct oral anticoagulants (577) 577
cardiology (575) 575
prospective studies (570) 570
oral anticoagulants (555) 555
follow-up studies (539) 539
blood coagulation - drug effects (538) 538
prevention (533) 533
dentistry (491) 491
apixaban (483) 483
internal medicine (455) 455
hemorrhage (444) 444
dose-response relationship, drug (439) 439
clinical trials (435) 435
dentistry, oral surgery & medicine (428) 428
dosage and administration (414) 414
health aspects (403) 403
drug administration schedule (400) 400
adolescent (397) 397
mortality (383) 383
anticoagulants - pharmacology (379) 379
blood. blood coagulation. reticuloendothelial system (374) 374
fibrillation (367) 367
thrombin (364) 364
animals (362) 362
cardiology. vascular system (361) 361
research (357) 357
incidence (355) 355
vitamin k (349) 349
medical research (346) 346
cardiovascular (342) 342
venous thromboembolism - drug therapy (337) 337
randomized controlled trials as topic (336) 336
atrial fibrillation - diagnosis (330) 330
heart (319) 319
usage (317) 317
cardiovascular diseases (313) 313
neurosciences & neurology (308) 308
practice guidelines as topic (308) 308
young adult (305) 305
prothrombin time (303) 303
anticoagulants - pharmacokinetics (298) 298
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8330) 8330
German (384) 384
Spanish (177) 177
French (114) 114
Portuguese (81) 81
Italian (40) 40
Japanese (32) 32
Russian (31) 31
Norwegian (11) 11
Polish (11) 11
Turkish (9) 9
Chinese (7) 7
Korean (7) 7
Dutch (6) 6
Hungarian (5) 5
Czech (4) 4
Hebrew (4) 4
Danish (3) 3
Finnish (2) 2
Romanian (2) 2
Serbian (2) 2
Croatian (1) 1
Georgian (1) 1
Lithuanian (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Guidelines on oral anticoagulation with warfarin – fourth edition
by Keeling, David and Baglin, Trevor and Tait, Campbell and Watson, Henry and Perry, David and Baglin, Caroline and Kitchen, Steve and Makris, Michael and British Comm Stand Haematology and British Committee for Standards in Haematology
British journal of haematology, ISSN 0007-1048, 08/2011, Volume 154, Issue 3, pp. 311 - 324
vitamin K antagonist | anticoagulation | warfarin | Vitamin K antagonist | Warfarin | Anticoagulation | Life Sciences & Biomedicine | Hematology | Science & Technology | Hematologic and hematopoietic diseases | Biological and medical sciences | Medical sciences | Pulmonary Embolism - prevention & control | Anticoagulants - administration & dosage | Drug Administration Schedule | Administration, Oral | Hemorrhage - therapy | Humans | Warfarin - adverse effects | Anticoagulants - therapeutic use | Drug Monitoring - methods | Anticoagulants - adverse effects | Warfarin - administration & dosage | Warfarin - therapeutic use | International Normalized Ratio | Drug Interactions | Perioperative Care - methods | Venous Thrombosis - prevention & control | Craniocerebral Trauma - complications | Hemorrhage - chemically induced | Platelet Aggregation Inhibitors - therapeutic use | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Guidelines on oral anticoagulation (warfarin): third edition – 2005 update
by Baglin, T. P and Keeling, D. M and Watson, H. G and British Comm Standards Haematology and British Committee for Standards in Haematology
British journal of haematology, ISSN 0007-1048, 02/2006, Volume 132, Issue 3, pp. 277 - 285
vitamin K antagonists | oral anticoagulation | guideline | warfarin | Guideline | Oral anticoagulation | Warfarin | Vitamin K antagonists | Life Sciences & Biomedicine | Hematology | Science & Technology | Hematologic and hematopoietic diseases | Biological and medical sciences | Medical sciences | Anticoagulants - administration & dosage | Administration, Oral | Heart Valve Prosthesis | Humans | Medical Audit - methods | Heparin, Low-Molecular-Weight - therapeutic use | Warfarin - administration & dosage | Neoplasms - drug therapy | Hemoglobinuria - drug therapy | Vitamin K - antagonists & inhibitors | Self Administration - methods | Perioperative Care - methods | Thromboembolism - drug therapy | Thrombosis - drug therapy | Thrombophilia - drug therapy | Electric Countershock - methods | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Oral anticoagulation use by patients with atrial fibrillation in Germany: Adherence to guidelines, causes of anticoagulation under-use and its clinical outcomes, based on claims-data of 183,448 patients
by Wilke, Thomas and Groth, Antje and Mueller, Sabrina and Pfannkuche, Matthias and Verheyen, Frank and Linder, Roland and Maywald, Ulf and Kohlmann, Thomas and Feng, You-Shan and Breithardt, Günter and Bauersachs, Rupert
Thrombosis and haemostasis, ISSN 0340-6245, 06/2012, Volume 107, Issue 6, pp. 1053 - 1065
Management of disease | Antiplatelet agents | Vitamin k-dependent factors | Peripheral Vascular Disease | Life Sciences & Biomedicine | Hematology | Cardiovascular System & Cardiology | Science & Technology | Fundamental and applied biological sciences. Psychology | Hematologic and hematopoietic diseases | Biological and medical sciences | Blood coagulation. Blood cells | Molecular and cellular biology | Medical sciences | Platelet diseases and coagulopathies | Multivariate Analysis | Stroke - prevention & control | Guideline Adherence - statistics & numerical data | Anticoagulants - administration & dosage | Risk Assessment | Administration, Oral | Atrial Fibrillation - drug therapy | Humans | Risk Factors | Logistic Models | Male | Thromboembolism - epidemiology | Anticoagulants - adverse effects | Germany - epidemiology | Practice Patterns, Physicians' - statistics & numerical data | Atrial Fibrillation - epidemiology | Thromboembolism - prevention & control | Female | Stroke - epidemiology | Aged | Hemorrhage - chemically induced | Odds Ratio | Drug Utilization - statistics & numerical data | Practice Guidelines as Topic
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Anticoagulation in Concomitant Chronic Kidney Disease and Atrial Fibrillation: JACC Review Topic of the Week
by Kumar, Shankar and Lim, Emma and Covic, Adrian and Verhamme, Peter and Gale, Chris P and Camm, A. John and Goldsmith, David
Journal of the American College of Cardiology, ISSN 0735-1097, 10/2019, Volume 74, Issue 17, pp. 2204 - 2215
atrial fibrillation | chronic kidney disease | stroke | direct oral anticoagulant | vitamin K antagonist | hemorrhage | warfarin | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Cardiac arrhythmia | Renal function | Hemodialysis | Clinical trials | Hemorrhage | Risk factors | Fibrillation | Ischemia | Thromboembolism | Heart diseases | Age | Heart failure | Hypertension | Anticoagulants | Stroke | Kidneys | Decision making | Mortality | Diabetes mellitus | Coronary artery | Health risks | FDA approval | Risk analysis | Coronary artery disease | Studies | Kidney diseases | Health risk assessment
Journal Article
Details down arrow
5. Full Text Patient characteristics associated with oral anticoagulation control: results of the Veterans AffaiRs Study to Improve Anticoagulation (VARIA)
by ROSE, A. J and HYLEK, E. M and OZONOFF, A and ASH, A. S and REISMAN, J. I and BERLOWITZ, D. R
Journal of thrombosis and haemostasis, ISSN 1538-7933, 10/2010, Volume 8, Issue 10, pp. 2182 - 2191
anticoagulants | quality of health care | ambulatory care | chronic disease | warfarin | Anticoagulants | Warfarin | Chronic disease | Quality of health care | Ambulatory care | Peripheral Vascular Disease | Life Sciences & Biomedicine | Hematology | Cardiovascular System & Cardiology | Science & Technology | Anticoagulants - administration & dosage | Administration, Oral | Atrial Fibrillation - drug therapy | United States | Veterans | Humans | Middle Aged | Anticoagulants - therapeutic use | Male | Warfarin - therapeutic use | International Normalized Ratio | Regression Analysis | Adult | Female | United States Department of Veterans Affairs | Aged | Cardiology - methods | Health care reform | Chronic diseases | Strategic planning (Business) | Bipolar disorder | Anticoagulants (Medicine) | Public health | Biometry | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Anticoagulation Reversal
by Simon, Erica M and Streitz, Matthew J and Sessions, Daniel J and Kaide, Colin G
Emergency medicine clinics of North America, ISSN 0733-8627, 08/2018, Volume 36, Issue 3, pp. 585 - 601
Warfarin | Heparin | Idarucizumab | Novel oral anticoagulants | Prothrombin complex concentrate | Anticoagulant reversal | Life Sciences & Biomedicine | Emergency Medicine | Science & Technology | Index Medicus
Journal Article
Details down arrow
7. Full Text Factors Affecting Quality of Anticoagulation Control Among Patients With Atrial Fibrillation on Warfarin The SAMe-TT2R2 Score
by Apostolakis, Stavros and Sullivan, Renee M and Olshansky, Brian and Lip, Gregory Y. H
Chest, ISSN 0012-3692, 11/2013, Volume 144, Issue 5, pp. 1555 - 1563
Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Stroke - prevention & control | Prospective Studies | Anticoagulants - administration & dosage | Follow-Up Studies | Administration, Oral | Humans | Middle Aged | Atrial Fibrillation - complications | Quality Indicators, Health Care | Male | Treatment Outcome | Atrial Fibrillation - physiopathology | Warfarin - administration & dosage | Dose-Response Relationship, Drug | Stroke - blood | Stroke - etiology | Blood Coagulation - drug effects | Electrocardiography | Female | Aged | Care and treatment | Warfarin | Atrial fibrillation | Patient outcomes | Anticoagulants (Medicine) | Dosage and administration | Research | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Prothrombin complex concentrate (Beriplex® P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial
by PABINGER, I and BRENNER, B and KALINA, U and KNAUB, S and NAGY, A and OSTERMANN, H and Beriplex P/N Anticoagulation Reversal Study Group and BERIPLEX® P/N ANTICOAGULATION REVERSAL STUDY GROUP
Journal of thrombosis and haemostasis, ISSN 1538-7933, 04/2008, Volume 6, Issue 4, pp. 622 - 631
blood coagulation factors | oral anticoagulants | prothrombin complex concentrates | anticoagulation reversal | hemorrhage | surgery | Blood coagulation factors | Hemorrhage | Anticoagulation reversal | Prothrombin complex concentrates | Surgery | Oral anticoagulants | Prospective Studies | Factor IX - therapeutic use | Humans | Middle Aged | Male | Factor IX - adverse effects | Hemorrhage - prevention & control | Vitamin K - therapeutic use | Aged, 80 and over | Adult | Factor X - therapeutic use | Female | Factor X - adverse effects | Factor VII - adverse effects | Coumarins - adverse effects | Factor VII - therapeutic use | Emergencies | Europe - epidemiology | Prothrombin - therapeutic use | Anticoagulants - adverse effects | Prothrombin - adverse effects | Hemostatics - adverse effects | International Normalized Ratio | Hemorrhage - drug therapy | Israel - epidemiology | Aged | Hemorrhage - chemically induced | Hemostatics - therapeutic use | Pulmonary Embolism - chemically induced | Drug Combinations | Prothrombin | Clinical trials | Thrombin | Anticoagulants (Medicine) | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Targeted Anticoagulation for Atrial Fibrillation Guided by Continuous Rhythm Assessment With an Insertable Cardiac Monitor: The Rhythm Evaluation for Anticoagulation With Continuous Monitoring (REACT.COM) Pilot Study
by PASSMAN, ROD and LEONG‐SIT, PETER and ANDREI, ADIN‐CRISTIAN and HUSKIN, ANNA and TOMSON, TODD T and BERNSTEIN, RICHARD and ELLIS, ETHAN and WAKS, JONATHAN W and ZIMETBAUM, PETER
Journal of cardiovascular electrophysiology, ISSN 1045-3873, 03/2016, Volume 27, Issue 3, pp. 264 - 270
atrial fibrillation | REVEAL | stroke | TIA | anticoagulation | implantable cardiac monitor | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Prospective Studies | Anticoagulants - administration & dosage | Follow-Up Studies | Administration, Oral | Atrial Fibrillation - drug therapy | Humans | Middle Aged | Electrocardiography, Ambulatory - methods | Male | Electrodes, Implanted | Atrial Fibrillation - physiopathology | Pilot Projects | Female | Aged | Atrial Fibrillation - diagnosis | Drug Delivery Systems - methods | Stroke (Disease) | Aspirin | Implants, Artificial | Prosthesis | Patient monitoring equipment | Atrial fibrillation | Anticoagulants (Medicine) | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Extended Anticoagulation for VTE
by Mai, Vicky and Guay, Charles-Antoine and Perreault, Laurie and Bonnet, Sébastien and Bertoletti, Laurent and Lacasse, Yves and Jardel, Sabine and Lega, Jean-Christophe and Provencher, Steeve
Chest, ISSN 0012-3692, 06/2019, Volume 155, Issue 6, pp. 1199 - 1216
mortality | extended anticoagulation | VTE | direct oral anticoagulant | vitamin K antagonist
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Venous and arterial thrombosis – pathogenesis and the rationale for anticoagulation
by A. G. G. Turpie and C. Esmon
Thrombosis and haemostasis, ISSN 0340-6245, 04/2011, Volume 105, Issue 4, pp. 586 - 596
Arterial thrombosis | Venous thrombosis | thrombin | factor Xa | anticoagulation | Review Article | Factor xa | Thrombin | Anticoagulation | Peripheral Vascular Disease | Life Sciences & Biomedicine | Hematology | Cardiovascular System & Cardiology | Science & Technology | Fundamental and applied biological sciences. Psychology | Cardiology. Vascular system | Hematologic and hematopoietic diseases | Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous | Biological and medical sciences | Blood coagulation. Blood cells | Molecular and cellular biology | Medical sciences | Blood and lymphatic vessels | Platelet diseases and coagulopathies | Factor Xa Inhibitors | Venous Thrombosis - drug therapy | Administration, Oral | Anti-Inflammatory Agents - pharmacology | Humans | Thrombin - antagonists & inhibitors | Venous Thrombosis - blood | Anticoagulants - therapeutic use | Clinical Trials as Topic | Coronary Thrombosis - drug therapy | Blood Coagulation - drug effects | Anticoagulants - pharmacology | Anti-Inflammatory Agents - therapeutic use | Coronary Thrombosis - blood
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights